Sweden· SE-20110809000393
NexoBrid 2 g Pulver och gel till gel
A medicinal product containing concentrate of proteolytic enzymes enriched in bromelain, registered in Sweden by MediWound Germany GmbH.
Checked against Swedish Medical Products Agency (Sweden) on
Informational only — not a medical device.
The record
At a glance
Swedish Medical Products Agency (Sweden)- Active substance
- Concentrate Of Proteolytic Enzymes Enriched In Bromelain
- Manufacturer
- MediWound Germany GmbH
- Country
- Sweden (SE)
- ATC code
- —
- Reimbursed
- Not published by this register
- Source register
- Swedish Medical Products Agency (Sweden)
- Last checked
- October 1, 2026
Packs & prices · 1
- se_varunummer20110809000393
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same medicine, other countries
Concentrate of proteolytic enzymes enriched in bromelain in 8 other countries
What each register calls a product with the same active substance — salts and hydrates count as the same.
- BelgiumNexobrid 2 gMediwound Germany
- CzechiaNEXOBRIDMediWound Germany GmbH, Rüsselsheim
- SpainNEXOBRID 2 g polvo y gel para gelMediwound Germany Gmbh
- GermanyBromelain-PosUrsapharm Arzneimittel Gmbh
- United KingdomBackOsamine tabletsOptima Consumer Health Ltd
- PolandNexoBridMediWound Germany GmbH
- NorwayNexoBridMediWound Germany GmbH
- SwitzerlandNexoBrid, poudre et gel pour gelTriskel INTEGRATED SERVICES SA
Authorised across Europe · EMA
The same active substance is authorised in 4 EEA countries. Names it is sold under:
- Germany · Bromelain-Pos, Bromelaintabletten Hysan
- Iceland · Nexobrid
- Liechtenstein · Nexobrid
- Norway · Nexobrid
Source: European Medicines Agency, Article 57 product data.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Swedish Medical Products Agency (Sweden). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/877fa453-2a18-4171-a825-36f85a785e03 GET /v1/drugs/877fa453-2a18-4171-a825-36f85a785e03?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"source": "lakemedelsverket",
"doc_types": [
"EPAR",
"EMA"
],
"se_npl_id": "20110809000393",
"product_page": "https://www.lakemedelsverket.se/sv/sok-lakemedelsfakta/lakemedel?id=20110809000393",
"product_doc_link": "https://www.ema.europa.eu/sv/documents/product-information/nexobrid-epar-product-information_sv.pdf"
}See everything about concentrate of proteolytic enzymes enriched in bromelain.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.